Cipher Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Cipher Capital’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,155	Closed	-$1.24M	–	645
2019 Q4	$1.24M	Buy	+11,155	New	+$1.15M	0.09%	279
2018 Q4	–	Sell	-3,014	Closed	-$332K	–	695
2018 Q3	$332K	Buy	+3,014	New	+$314K	0.06%	336
2018 Q2	–	Sell	-11,716	Closed	-$972K	–	706
2018 Q1	$972K	Sell	11,716 -2,537	-18%	-$225K	0.12%	269
2017 Q4	$1.3M	Buy	14,253 +923	+7%	+$76.8K	0.1%	308
2017 Q3	$1.01M	Buy	13,330 +2,794	+27%	+$211K	0.08%	383
2017 Q2	$791K	Sell	10,536 -5,285	-33%	-$366K	0.06%	403
2017 Q1	$1.03M	Buy	15,821 +10,399	+192%	+$612K	0.08%	365
2016 Q4	$299K	Sell	5,422 -10,924	-67%	-$599K	0.02%	559
2016 Q3	$924K	Buy	+16,346	New	+$802K	0.06%	458

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Cipher Capital's PRAH Position: Q1 2020 in Review

Cipher Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 11,155 shares — an estimated $1.24M sold.

Cipher Capital first reported a position in PRAH in Q3 2016 and held it in 9 quarters. The position peaked at $1.3M in Q4 2017. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

Cipher Capital reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
Cipher Capital sold 11,155 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $1.24M.
Cipher Capital first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 9 quarters.
Cipher Capital's PRA Health Sciences, Inc. position peaked at $1.3M in Q4 2017.
301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Cipher Capital's 13F filing for Q1 2020, filed 15 May 2020.